Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Chelsie Napiza

Hershey's CEO Claims Ozempic Breath is Driving Massive Surge in Mint and Gum Sales Across the United States

A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. (Credit: Getty image)

Hershey's chief executive has credited the spread of Ozempic and other weight-loss drugs for an 8% jump in sales of the company's Ice Breakers mints and gum, pointing to a side effect of the medication that the broader industry had not foreseen as a revenue driver.

Speaking on Hershey's pre-recorded Q1 2026 earnings call on 30 April 2026, CEO Kirk Tanner said the company was seeing 'strong demand' for breath-freshening products he attributed directly to what he called 'GLP-1 adoption.'

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.